Skip to main content
. 2020 Oct 8;10(6):e203. doi: 10.1002/ctm2.203

TABLE 1.

General information on participating population‐based registries

Excluded cases 1
Source Country Diagnosis period Registered cases DCO/autopsy Not pathologically diagnosed Not pathologically eligible 2 Precancerous/in situ Unknown metastasis Metastatic Analyzed cases
SEER‐18 3 The US Jan. 2004‐Dec. 2015 79 091 855 (1) 983 (1) 10 020 (13) 780 (1) 5344 (7) 23 280 (29) 37 829
NCR Netherlands Jan. 2005‐Dec. 2014 18346 48 (< 1) 309 (2) 78 (< 1) 343 (2) 711 (4) 7112 (39) 9745
BCR Belgium Jan.2004‐Dec. 2013 14122 NA 80 (1) 1670 (12) 23 (< 1) 3076 (22) 2805 (20) 6468
SCR Sweden Jan. 2006‐Aug. 2016 7909 NA 169 (2) 0 (0) 0 (0) 471 (6) 2783 (35) 4486
CRN Norway Jan. 2003‐Dec. 2014 6194 53 (1) 299 (5) 438 (7) 5 (< 1) 362 (6) 1779 (29) 3258
CRS Slovenia Jan. 2003‐Dec. 2013 5265 NA 241 (5) 231 (4) 9 (< 1) 236 (4) 1655 (31) 2893
ECR Estonia Jan. 2009‐Dec. 2014 2394 67 (3) 139 (6) 114 (5) 0 (0) 245 (10) 801 (33) 1028
1

Shown as n (percentage [%]).

2

Based on criteria shown in Supporting information Table S3. Preliminary case selection according to cancer histology had been performed by the national cancer registries of the Netherlands and Sweden.

3

Data of the year 2003 were not analyzed, as the TNM stage (version 6/7) information was unavailable.

SEER, Surveillance, Epidemiology, and End Results Program; NCR, Netherlands Cancer Registry; BCR, Belgian Cancer Registry; SCR, Swedish Cancer Registry; CRN, Cancer Registry of Norway; CRS, Cancer Registry of Slovenia; ECR, Estonian Cancer Registry; DCO, death certificate only; NA, not available.